What is the current market size and growth outlook for the animal parasiticides market?

The global animal parasiticides market is valued at approximately USD 12.98 billion in 2026 and is projected to reach USD 17.50 billion by 2031, growing at a CAGR of 6.2%. This steady expansion is driven by rising companion animal ownership and livestock health needs. Revenue growth strategies include portfolio diversification and premium long-acting formulations. Market players are leveraging emerging markets and digital veterinary ecosystems to accelerate adoption and recurring revenues. Read More

What are the primary growth drivers shaping the animal parasiticides market?

Key growth drivers include increasing pet ownership, rising awareness of zoonotic diseases, and the growing emphasis on preventive animal healthcare. Additionally, demand for high-quality animal-derived food products is reinforcing parasite control adoption. Strategic expansion into companion animal segments and preventive care models is unlocking new revenue streams. Technology-enabled diagnostics and treatment compliance tools further strengthen market penetration. Read More

Which market segments and applications are driving the highest demand?

Companion animals dominate the market with over 57% share, driven by higher healthcare spending and frequent veterinary visits. Ectoparasiticides lead product demand due to persistent flea and tick infestations. Veterinary hospitals and clinics remain the primary distribution channel, accounting for over 60% share. Growth opportunities lie in livestock productivity enhancement and integrated parasite management across animal farms. Read More

What are the key technological advancements influencing the market landscape?

Innovation is centered on long-acting formulations, combination endectocides, and advanced delivery mechanisms such as oral palatable tablets and topical solutions. These technologies improve compliance and broaden parasite coverage. Integration of digital health tools, predictive analytics, and smart veterinary platforms is transforming preventive care. Such advancements are enabling differentiation and premium pricing strategies for manufacturers. Read More

What regulatory factors are impacting market growth and commercialization?

Stringent regulations on parasiticide residues in food-producing animals and varying regional compliance frameworks pose significant barriers. Regulatory approvals increase time-to-market and R&D costs, particularly for livestock applications. However, strong regulatory oversight also enhances product safety and trust, creating long-term competitive advantages for compliant players. Companies are investing in regulatory intelligence and global harmonization strategies. Read More

What are the major challenges and risks faced by industry stakeholders?

Rising parasite resistance to existing active ingredients is a critical challenge, threatening product efficacy and lifecycle sustainability. Additionally, high costs of advanced combination therapies may limit adoption in price-sensitive markets. Supply chain complexities and evolving parasite patterns add further uncertainty. Companies must invest in continuous innovation and resistance management strategies to mitigate long-term risks. Read More

Which regions and emerging markets present the highest growth opportunities?

Latin America is projected to register the highest CAGR, driven by expanding livestock production and increasing veterinary infrastructure. Emerging markets in Asia-Pacific and Africa also offer untapped potential due to rising disposable incomes and growing awareness of animal health. Strategic localization, partnerships with veterinary networks, and affordable product innovations are key to capturing these opportunities. Read More

What are the future trends and disruptive forces shaping the animal parasiticides market?

The market is moving toward integrated parasite management, combining pharmaceuticals with digital monitoring and preventive care ecosystems. Long-acting injectables, biologics, and eco-friendly parasiticides are emerging as disruptive innovations. Strategic collaborations between pharma, agri-tech, and veterinary platforms are accelerating product development. Sustainability, resistance mitigation, and precision animal health will define the next phase of competitive differentiation. Read More

Animal Parasiticides Market Report 2026-2031, By Type, End user, and Geo

DESCRIPTION
TABLE OF CONTENTS
METHODOLOGY
DOWNLOAD PDF

Animal Parasiticides Market by Type (Ectoparasiticide, Endoparasiticide, Endectocide, Spray, Feed Additives), Animal Type (Dog, Cat, Horse, Cattle, Pig, Poultry), End user (Hospital, Animal farm, Home Care Setting) & Region - Global Forecast to 2031

USD 17.50 BN

MARKET SIZE, 2031

CAGR 6.2%

(2026-2031)

450

REPORT PAGES

400

MARKET TABLES

ANIMAL PARASITICIDES MARKET SIZE, SHARE & GROWTH SNAPSHOT

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global animal parasiticides market is projected to grow from USD 12.98 billion in 2026 to USD 17.50 billion by 2031, at a CAGR of 6.2% during the forecast period. The market was valued at USD 12.30 billion in 2025. The market is fueled by the increasing cases of ecto- and endoparasites in companion and food-producing animals, growing focus on the preventive management of parasites, and the rising number of pet owners worldwide. Advances in the development of parasiticides, such as combination therapies and long-acting treatments, along with the growing awareness of the transmission of zoonotic diseases, are also fueling the adoption of effective parasite control measures.

KEY TAKEAWAYS

By Region

Asia Pacific is expected to register the highest CAGR of 7.5% during the forecast period (2026-2031).
By Type

By type, the endectocide segment is expected to register the highest CAGR of 7.3% during the forecast period.
By Animal Type

By animal type, the companion animals segment accounted for the largest market share (55.6%) in 2025.
By End User

By end user, the veterinary hospitals & clinics segment dominated the market with a share of 43.6% in 2025.
Competitive Landscape - Key Players

Zoetis Services LLC, Merck & Co., Inc., and Elanco were identified as some of the star players in the animal parasiticides market, given their extensive global reach and comprehensive product portfolios.
Competitive Landscape - Startups

Biogénesis Bagó, and Chanelle Pharma, among others, have distinguished themselves among startups and SMEs due to their specialized veterinary expertise and focused product capabilities.

The animal parasiticides market is expanding rapidly. The major factors contributing to this growth are increased expenditure on pet healthcare, the rising awareness of the need for parasite prevention throughout the year, and the strong market receptivity to novel, easy-to-administer treatment solutions. Some new technologies defining the market are the long-acting and extended-release formulations, combination endectocide products that provide broad-spectrum parasite control in a single dose, and advanced topical and oral delivery mechanisms that not only increase drug efficacy but also make it easier for patients to follow the treatment regimen. Besides that, the increasing use of digital health tools and data analytics for preventive care and ensuring treatment adherence is making it easier for people to adopt products. Moreover, pharmaceutical companies, veterinary networks, and technology providers' widening partnerships are indications of the accelerated product development and commercialization activities resulting in the animal parasiticides market's continued growth.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The effect on the consumer businesses in the animal parasiticides market is due to the rising focus on preventive pet care, the prevalence of parasitic infections, and the concerns about resistance and zoonotic transmission. Veterinary practices, animal healthcare firms, and pet care operators are becoming more and more reliant on safe, broad-spectrum, and long-acting parasiticide solutions that provide year-round protection, improve owner compliance, and provide better outcomes. The need to provide convenient, fast-acting, and comprehensive parasite control while adjusting to the changing patterns of parasites and treatment modalities based on lifestyle trends is fueling the adoption of innovative parasiticide solutions. The rising need for effective and reliable parasitic protection is fueling the reliance on innovative parasiticide solution providers, which has a significant influence on the market.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers

Impact
Level

Rising pet ownership and increased focus on preventive animal healthcare
Growing prevalence of ecto- and endoparasites

RESTRAINTS

Impact
Level

Strict regulations on parasiticide residues in food-producing animals
High cost of premium and combination parasiticide products

OPPORTUNITIES

Impact
Level

Development of long-acting, combination, and novel-delivery parasiticides
Expansion of parasiticide adoption in emerging markets

CHALLENGES

Impact
Level

Increasing parasite resistance to existing active ingredients
Stringent regulatory approval processes and varying regional compliance requirements

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising pet ownership and increased focus on preventive animal healthcare

The increasing number of pet owners across the globe, especially in urban and developing countries, along with the rising awareness of preventive animal healthcare, is a major driving factor for the animal parasiticides market. Pet owners and animal farmers are now focusing on the regular prevention of parasites to prevent costly treatments, losses, and zoonoses. This is further fueled by the development of veterinary care, rising disposable income, and the humanization of pets.

Restraint: Strict regulations on parasiticide residues in food-producing animals

Market expansion in the livestock sector remains constrained because strict regulations that control parasiticide levels in food-producing animals create obstacles for market development. Regulatory bodies enforce maximum residue limits (MRLs) to ensure consumer food safety, which results in increased development costs and extended product approval periods, and limits the availability of specific active ingredients. Product launches become more challenging for manufacturers operating in multiple regions because they must deal with different regional regulations, which create additional compliance requirements, in turn limiting market growth for their products.

Opportunity: Development of long-acting, combination, and novel-delivery parasiticides

The market shows substantial potential to expand through the introduction of long-acting parasiticides, combination products, and upcoming delivery systems. Products that provide extended protection, target multiple parasites, and reduce dosing frequency improve compliance among animal owners and veterinarians. Premiumization and product differentiation in the parasiticides market will experience growth because of ongoing formulation technology advancements, which include sustained-release injectables and palatable oral formulations, along with the rising market presence of emerging economies.

Challenge: Increasing parasite resistance to existing active ingredients

The animal parasiticides market faces its main obstacle because parasites develop resistance against all current active ingredients. The repeated use of chemical classes has led to their decreased effectiveness against specific parasite populations, which are found in intensive livestock systems. The challenge requires higher R&D expenses while it delays product development, and the market requires integrated parasite management with active ingredient rotation and better surveillance systems to achieve sustainable growth.

ANIMAL PARASITICIDES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Provides a wide parasiticide portfolio for companion animals (e.g., Simparica, Revolution/Stronghold) and livestock, along with vaccines, diagnostics, and other animal health solutions marketed globally.	Enables broad, cross-species parasite control and improves preventive care and herd/clinic productivity through well-known and trusted brands.
	Develops and commercializes parasiticides such as the BRAVECTO range, including long-acting formulations for fleas, ticks, and internal parasites in pets and livestock worldwide.	Increases treatment adherence with extended-duration protection and reduces parasite load, supporting better outcomes for veterinarians and owners.
	Offers parasiticides for both companion and production animals, supported by strong global R&D capabilities and extensive distribution networks.	Delivers effective, preventive, and therapeutic parasite control across species and helps meet the everyday needs of veterinary practices in Asia Pacific.
	Supplies parasiticides as part of a broader veterinary pharmaceutical portfolio for pets and livestock, targeting fleas, ticks, mites, internal worms, and related conditions.	Improves animal health and farm efficiency by providing veterinarians and farmers with dependable parasite management options.
	Provides a diverse range of external and internal parasiticides for companion animals and livestock, backed by localized subsidiaries and regional R&D.	Offers region-tailored parasite control solutions that strengthen veterinary care and support consistent prevention and treatment.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem in the animal parasiticides market consists of different players, each of whom is crucial to the development, distribution, and use of solutions for controlling parasites. At the top of the list are animal health firms that are developing and producing parasiticides for companion animals and farm animals. These are followed by veterinary distributors and practices like veterinary hospitals & clinics and animal farms, which are the main end users of these products. Emerging players include technology firms that are providing online platforms for monitoring treatment compliance and resistance.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Animal Parasiticides Market, By Type

In 2025, ectoparasiticides held the largest share of the animal parasiticides market because external parasites like fleas, ticks, and mites infest both companion animals and livestock. The ongoing need for preventive treatment solutions exists because these parasites remain present in the environment. The segment experienced growth because people widely adopted topical treatments, collars, and oral formulations to treat fleas and ticks. The market dominance of ectoparasiticides receives support from their common application in preventive care routines.

Animal Parasiticides Market, By Animal Type

In 2025, the companion animal segment held the largest share of the animal parasiticides market because of the increased adoption of pets, which led to higher spending on preventive health treatments. The ongoing requirement for parasiticides results from companion animals receiving continuous flea and tick and internal parasite treatment throughout the year. The segment remains dominant because customers maintain high veterinarian contact while premium long-lasting products stay on the market and awareness about parasite diseases increases.

Animal Parasiticides Market, By End User

By end user, the animal parasiticides market is estimated to be dominated by veterinary hospitals and clinics, because these facilities serve as the main location for diagnosing parasites and prescribing their treatment. Veterinary doctors help pet owners and livestock farmers choose the right products and preventive treatments, resulting in them using more prescription-based and high-priced parasiticides through veterinary clinics. The combination of long-acting products and combination products, as well as the increase in preventive veterinary visits, has established veterinary hospitals and clinics as the leading centers for distributing and using parasiticide products.

REGION

Asia Pacific to be fastest-growing region in global animal parasiticides market during forecast period

Asia Pacific is projected to be the fastest-growing regional market for animal parasiticides, driven by rising pet ownership, expanding livestock production, and increasing awareness regarding animal health and parasite prevention. Growing demand for advanced veterinary care, improving access to animal healthcare products, and increasing adoption of ectoparasiticides and endoparasiticides are further supporting market growth in the region. In addition, rapid urbanization, increasing disposable income, and government initiatives to strengthen animal health infrastructure are contributing to the accelerated expansion of the animal parasiticides market across Asia Pacific.

ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX

In the animal parasiticides market, Zoetis (Star) is supported by a wide range of ectoparasiticides, endoparasiticides, and endectocides for both companion and production animals in its portfolio. It is supported with the leadership of the company from the continued investment in R&D, product innovations, a global distribution and veterinary network that facilitates deep market penetration and brand loyalty. Meanwhile, Ceva(Emerging Leader) is turning out to be a great challenger, especially in the field of companion animal parasiticides, carrying the torch of a veterinary-led approach through the offerings of the company, differentiated formulations, and a progressive move to the new regional markets.

animal-parasiticide-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

Zoetis Services LLC (US)
Merck & Co., Inc. (US)
Elanco (US)
Boehringer Ingelheim International GmbH (Germany)
Virbac (France)
Vetoquinol (France)
Dechra Pharmaceuticals PLC (UK)
Phibro Animal Health Corporation (US)
Norbrook (UK)
Bimeda Corporate (Ireland)
krka (Slovenia)
Ourofino Saúde Animal (Brazil)
Sequent (India)
PetIQ, LLC (US)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size in 2025 (Value)	USD 12.30 BN
Market Forecast in 2031 (Value)	USD 17.50 BN
Growth Rate	CAGR of 6.2% from 2026 to 2031
Years Considered	2024-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD Million/Billion), Volume (Thousand Units)
Report Coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered	By Type: Ectoparasiticides Endoparasiticides Endectocides By Animal Type: Companion Animals Livestock By End User: Veterinary Hospitals & Clinics Animal Farms Home Care Settings
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: ANIMAL PARASITICIDES MARKET REPORT CONTENT GUIDE

animal-parasiticide-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Product Analysis	Compared different key parasiticide types for animals, such as ectoparasiticides, endoparasiticides, and endectocides. Evaluated whether used for prevention or treatment, by animal type (pets versus livestock), and product differentiation among major companies.	Facilitated clarity into product maturity, usage dynamics, and demand gaps, thereby aiding in portfolio optimization, pricing decisions, and prioritized focus on high-growth parasiticide markets.
Company Information	Profiled major animal health firms such as Zoetis, MSD Animal Health, Boehringer Ingelheim, Elanco, Virbac, and major local players.	Assessed their product portfolios, R&D investments, manufacturing, and distribution networks.
Geographic Analysis	Carried out in-depth regional analysis in China, India, Japan, Australia, and Rest of APAC regarding the prevalence of parasitic diseases, farm animal density, and companion animal market trends.	Assisted in the development of regional strategies for finding the fastest-growing countries, the level of complexity for regulations, opportunities for localizations, and markets to pursue in the APAC region.

RECENT DEVELOPMENTS

July 2025 : Merck & Co., Inc. announced that the US FDA approved BRAVECTO QUANTUM, an extended-release injectable suspension administered once annually to provide treatment and protection for dogs against fleas and ticks.
April 2025 : Zoetis Services LLC reported that the US FDA approved an expanded indication for Simparica Trio, a combination canine parasiticide that also prevents flea-transmitted tapeworm infections.
April 2024 : Zoetis Services LLC and Phibro Animal Health Corporation entered into a definitive agreement under which Phibro acquired Zoetis’ medicated feed additive portfolio, including selected water-soluble products and related assets, for USD 350 million.

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Emerging economies drive market growth amid rising zoonotic diseases and regulatory challenges.

4.1

INTRODUCTION

4.2

MARKET DYNAMICS

4.2.1

DRIVERS

4.2.1.1

INCREASING ZOONOTIC & VECTOR-BORNE DISEASE BURDEN, CREATING MANDATORY TREATMENT

4.2.1.2

EXPANDING COMPANION ANIMAL POPULATION AND PET OWNERSHIP

4.2.1.3

INCREASING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS

4.2.2

RESTRAINTS

4.2.2.1

GROWING RESISTANCE TO PARASITICIDES

4.2.2.2

STRINGENT REGULATORY APPROVAL PROCESSES FOR VETERINARY DRUGS

4.2.3

OPPORTUNITIES

4.2.3.1

HIGH GROWTH POTENTIAL OF EMERGING ECONOMIES

4.2.4

CHALLENGES

4.2.4.1

UNEVEN REGULATORY APPROVAL TIMELINES ACROSS KEY MARKETS, CREATING ACCESS INEQUALITIES

4.2.4.2

BALANCING ANIMAL WELFARE, PRODUCTIVITY, AND COMPLIANCE REQUIREMENTS

4.3

UNMET NEEDS AND WHITE SPACES

4.4

INTERCONNECTED MARKET AND CROSS-SECTOR OPPORTUNITIES

4.4.1

INTERCONNECTED MARKETS

4.4.2

CROSS-SECTOR OPPORTUNITIES

4.5

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

4.5.1

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

INDUSTRY TRENDS

Navigate industry shifts with in-depth pricing and competitive analysis in animal healthcare.

5.1

PORTER’S FIVE FORCE ANALYSIS

5.1.1

THREAT OF NEW ENTRANTS

5.1.2

THREAT OF SUBSTITUTES

5.1.3

BARGAINING POWER OF SUPPLIERS

5.1.4

BARGAINING POWER OF BUYERS

5.1.5

INTENSITY OF COMPETITIVE RIVALRY

5.2

MACROECONOMIC INDICATORS

5.2.1

INTRODUCTION

5.2.2

GDP TRENDS AND FORECAST

5.2.3

GDP, CURRENT PRICES (BILLIONS OF U.S. DOLLARS)

5.2.4

GDP: CURRENT PRICES (USD BILLION)

5.2.5

TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY

5.2.6

TRENDS IN GLOBAL ANIMAL PARASITICIDES INDUSTRY

5.3

VALUE CHAIN ANALYSIS

5.4

ECOSYSTEM ANALYSIS

5.5

PRICING ANALYSIS

5.5.1

AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY KEY PLAYER, 2023–2025

5.5.1.1

AVERAGE SELLING PRICE TREND OF ECTOPARASITICIDES, BY KEY PLAYER, 2023−2025

5.5.1.2

AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDES, BY KEY PLAYER, 2023−2025

5.5.1.3

AVERAGE SELLING PRICE TREND OF ENDECTOCIDES, BY KEY PLAYER, 2023−2025

5.5.2

AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY REGION, 2023–2025

5.5.2.1

AVERAGE SELLING PRICE TREND OF POUR-ON ECTOPARASITICIDES (USD PER STANDARD TREATMENT UNIT), BY REGION, 2023−2025

5.5.2.2

AVERAGE SELLING PRICE TREND OF SPRAY ECTOPARASITICIDES (USD PER STANDARD TREATMENT UNIT), BY REGION, 2023−2025

5.5.2.3

AVERAGE SELLING PRICE TREND OF TABLET ECTOPARASITICIDES (USD PER STANDARD TREATMENT UNIT), BY REGION, 2023−2025

5.5.2.4

AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDE ORAL SOLIDS (USD PER STANDARD TREATMENT UNIT), BY REGION, 2023−2025

5.5.2.5

AVERAGE SELLING PRICE TREND OF INJECTABLE ENDECTOCIDES (USD PER STANDARD TREATMENT UNIT), BY REGION, 2023−2025

5.6

TRADE ANALYSIS

5.6.1

IMPORT DATA FOR HS CODE 30, 2021–2025

5.6.2

IMPORT SCENARIO (HS CODE 30)

5.6.3

EXPORT DATA FOR HS CODE 30, 2021–2025

5.6.4

EXPORT SCENARIO (HS CODE 30)

5.7

KEY CONFERENCES AND EVENTS IN 2026–2027

5.8

TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS

5.9

INVESTMENT AND FUNDING SCENARIO

5.10

CASE STUDY ANALYSIS

5.10.1

CASE STUDY 1: BROAD-SPECTRUM COMBINATION ECTOPARASITICIDE + ENDOPARASITICIDE (ZOETIS – SIMPARICA TRIO)

5.10.2

CASE STUDY 2: FIRST BROAD-SPECTRUM FELINE TOPICAL ENDECTOCIDE (BOEHRINGER INGELHEIM – NEXGARD COMBO)

5.10.3

CASE STUDY 3: BROADEST-SPECTRUM CANINE ORAL PARASITICIDE WITH FOUR ACTIVE INGREDIENTS (ELANCO – CREDELIO QUATTRO)

5.11

ANIMAL PARASITICIDES MARKET: IMPACT OF 2025 US TARIFF

5.11.1

INTRODUCTION

5.11.2

KEY TARIFF RATES

5.11.3

PRICE IMPACT ANALYSIS

5.11.4

IMPACT ON COUNTRY/REGION

5.11.5

IMPACT ON END USERS

5.11.5.1

VETERINARY HOSPITALS & CLINICS

5.11.5.2

HOME CARE SETTINGS

5.11.5.3

ANIMAL FARMS

STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION

Unlock competitive advantage by integrating AI and patents in animal parasiticides innovation.

6.1

TECHNOLOGY ANALYSIS

6.1.1

KEY EMERGING TECHNOLOGIES

6.1.1.1

LONG-ACTING/EXTENDED-RELEASE PARASITICIDES

6.1.1.2

NOVEL MULTI-PARASITE COMBINATION THERAPIES

6.1.2

COMPLEMENTARY TECHNOLOGIES

6.1.2.1

IMMUNOMODULATORS FOR HOST-ASSISTED PARASITIC CONTROL

6.1.2.2

NANOBIOSENSORS AND RAPID DIAGNOSTICS FOR PARASITIC DETECTION

6.1.3

ADJACENT TECHNOLOGIES

6.1.3.1

ENTOMOPATHOGENIC FUNGI (EPF) FOR TICKS AND ECTOPARASITES

6.1.3.2

PRECISION LIVESTOCK FARMING SENSORS AND WEARABLES

6.2

TECHNOLOGY/PRODUCT ROADMAP

6.3

PATENT ANALYSIS

6.3.1

PUBLICATION TRENDS FOR ANIMAL PARASITICIDES

6.3.1.1

INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS AND JURISDICTION FOR ANIMAL PARASITICIDES, JANUARY 2015–MAY 2026

6.3.2

LIST OF MAJOR PATENTS, 2023–2026

6.4

FUTURE APPLICATIONS

6.4.1

PRECISION LIVESTOCK HEALTH MANAGEMENT

6.4.2

ONCOLOGY AND CHRONIC DISEASE MANAGEMENT

6.4.3

REPRODUCTIVE AND FERTILITY ENHANCEMENT IN LIVESTOCK

6.4.4

INTEGRATED DISEASE SURVEILLANCE AND OUTBREAK CONTROL

6.5

IMPACT OF AI/GENERATIVE AI ON ANIMAL PARASITICIDES MARKET

6.5.1

INTRODUCTION

6.5.2

MARKET POTENTIAL IN ANIMAL PARASITICIDES ECOSYSTEM

6.5.3

AI USE CASES

6.5.4

KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

Unlock strategic insights into buying behaviors and unmet needs driving animal healthcare innovation.

102

7.1

DECISION-MAKING PROCESS

7.2

KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA

7.2.1

KEY STAKEHOLDERS IN BUYING PROCESS

7.2.2

BUYING CRITERIA

7.3

ADOPTION BARRIERS & INTERNAL CHALLENGES

7.4

UNMET NEEDS IN VARIOUS END-USE SETTINGS

7.4.1

VETERINARY HOSPITALS & CLINICS

7.4.2

LIVESTOCK FARMS

7.4.3

HOME CARE SETTINGS

7.5

MARKET PROFITABILITY

7.5.1

PRODUCT INNOVATION AND DIFFERENTIATION

7.5.2

EXPANSION OF COMPANION ANIMAL HEALTHCARE SPENDING

7.5.3

OPERATIONAL SCALE AND DISTRIBUTION EFFICIENCY

SUSTAINABILITY AND REGULATORY LANDSCAPE

Navigate global regulatory frameworks to enhance sustainable practices in veterinary medicinal products.

109

8.1

REGULATORY LANDSCAPE

8.1.1

REGULATORY FRAMEWORK

8.1.1.1

NORTH AMERICA

8.1.1.2

EUROPE

8.1.2

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

8.1.3

INDUSTRY STANDARDS

8.1.3.1

VICH GUIDELINES (INTERNATIONAL COOPERATION ON HARMONIZATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF VETERINARY MEDICINAL PRODUCTS)

8.1.3.2

GOOD MANUFACTURING PRACTICE (GMP) STANDARDS – PIC/S GUIDE (PE 009 SERIES)

8.1.3.3

CODEX ALIMENTARIUS STANDARDS FOR VETERINARY DRUG RESIDUES (CXM 2 – MAXIMUM RESIDUE LIMITS)

8.2

SUSTAINABILITY INITIATIVES

8.2.1

ENERGY-EFFICIENT MANUFACTURING & CARBON REDUCTION IN ANIMAL PARASITICIDES MARKET

8.2.2

SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES

8.2.3

CERTIFICATIONS, LABELING, AND ECO-STANDARDS

ANIMAL PARASITICIDES MARKET, BY TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Units | 56 Data Tables

116

9.1

INTRODUCTION

9.2

ECTOPARASITICIDES

9.2.1

POUR-ONS & SPOT-ONS

9.2.1.1

EASE OF APPLICATION AND BROAD SPECTRUM ACTIVITY TO DRIVE CONTINUED ADOPTION

9.2.1.2

GLOBAL VOLUME ANALYSIS OF POUR-ONS & SPOT-ONS, 2024–2031 (THOUSAND UNITS)

9.2.2

ORAL TABLETS

9.2.2.1

HIGH MEDICATION COMPLIANCE AND EASE OF ADMINISTRATION TO DRIVE MARKET

9.2.2.2

GLOBAL VOLUME ANALYSIS OF ORAL TABLETS, 2024–2031 (THOUSAND UNITS)

9.2.3

SPRAYS

9.2.3.1

LOW PRICE AND CONVENIENCE TO DRIVE MARKET IN EMERGING ECONOMIES AND LIVESTOCK SECTOR

9.2.3.2

GLOBAL VOLUME ANALYSIS OF SPRAYS, 2024–2031 (THOUSAND UNITS)

9.2.4

DIPS

9.2.4.1

HIGH POPULARITY ENSURES SUSTAINED END-USER DEMAND

9.2.4.2

GLOBAL VOLUME ANALYSIS OF DIPS, 2024–2031 (THOUSAND UNITS)

9.2.5

EAR TAGS

9.2.5.1

HIGH EFFECTIVENESS IN CONTROLLING FLIES AROUND CATTLE DRIVES MARKET

9.2.5.2

GLOBAL VOLUME ANALYSIS OF EAR TAGS, 2024–2031 (THOUSAND UNITS)

9.2.6

COLLARS

9.2.6.1

GROWING PREVALENCE OF INFECTIONS IN COMPANION ANIMALS TO DRIVE ADOPTION

9.2.6.2

GLOBAL VOLUME ANALYSIS OF COLLARS MARKET, 2024–2031 (THOUSAND UNITS)

9.2.7

OTHER ECTOPARASITICIDES

9.3

ENDOPARASITICIDES

9.3.1

ORAL LIQUIDS

9.3.1.1

BROAD-SPECTRUM ACTIVITY TO DRIVE ADOPTION ACROSS YOUNG ANIMALS AND INTENSIVE LIVESTOCK SYSTEMS

9.3.1.2

GLOBAL VOLUME ANALYSIS OF ORAL LIQUIDS, 2024–2031 (THOUSAND UNITS)

9.3.2

ORAL SOLIDS

9.3.2.1

EMERGENCE OF INTERNAL PARASITIC INFECTIONS IN DOGS TO DRIVE MARKET

9.3.2.2

GLOBAL VOLUME ANALYSIS OF ORAL SOLIDS, 2024–2031 (THOUSAND UNITS)

9.3.3

INJECTABLES

9.3.3.1

GLOBAL VOLUME ANALYSIS OF INJECTABLES, 2024–2031 (THOUSAND UNITS)

9.3.3.2

STANDARD/SHORT-ACTING INJECTABLES

9.3.3.2.1

VETERINARY PREFERENCE FOR FAST-ACTING INJECTABLE FORMULATIONS IN ACUTE PARASITIC INFECTIONS DRIVES MARKET GROWTH

9.3.3.3

LONG-ACTING/EXTENDED-RELEASE INJECTABLES

9.3.3.3.1

EMERGENCE OF INTERNAL PARASITIC INFECTIONS IN DOGS TO DRIVE MARKET

9.3.4

FEED ADDITIVES

9.3.4.1

CAN BE ADMINISTERED TO LARGE NUMBER OF ANIMALS AT ONCE

9.3.4.2

GLOBAL VOLUME ANALYSIS OF FEED ADDITIVES, 2024–2031 (THOUSAND UNITS)

9.3.5

OTHER ENDOPARASITICIDES

9.4

ENDECTOCIDES

9.4.1

ORAL ENDECTOCIDES

9.4.1.1

GROWING PET OWNER PREFERENCE FOR SYSTEMIC ALL-IN-ONE PROTECTION TO ACCELERATE ORAL ENDECTOCIDE DEMAND

9.4.1.2

GLOBAL VOLUME ANALYSIS OF ORAL ENDECTOCIDES, 2024–2031 (THOUSAND UNITS)

9.4.2

INJECTABLE ENDECTOCIDES

9.4.2.1

SINGLE-INJECTION DUAL-ACTION CONVENIENCE UNDERPINS DOMINANCE IN CATTLE AND SWINE PRODUCTION SYSTEMS

9.4.2.2

GLOBAL VOLUME ANALYSIS OF INJECTABLE ENDECTOCIDES, 2024–2031 (THOUSAND UNITS)

9.4.3

TOPICAL ENDECTOCIDES

9.4.3.1

CONVENIENCE, ZERO-INJECTION COMPLIANCE, AND EXPANDING MULTI-SPECTRUM TOPICAL FORMULATIONS SUSTAIN DEMAND

9.4.3.2

GLOBAL VOLUME ANALYSIS OF TOPICAL ENDECTOCIDES, 2024–2031 (THOUSAND UNITS)

ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables

163

10.1

INTRODUCTION

10.2

COMPANION ANIMALS

10.2.1

DOGS

10.2.1.1

INCREASING ADOPTION OF DOGS TO DRIVE MARKET GROWTH

10.2.2

CATS

10.2.2.1

RISING FELINE PARASITICIDE ADOPTION, LOW PREVENTIVE COMPLIANCE, AND BROAD-SPECTRUM PRODUCT LAUNCHES DRIVE GROWTH

10.2.3

HORSES

10.2.3.1

HIGHER RISK OF TRAUMATIC INJURIES IN HORSES TO DRIVE DEMAND

10.2.4

OTHER COMPANION ANIMALS

10.3

LIVESTOCK ANIMALS

10.3.1

CATTLE

10.3.1.1

GASTROINTESTINAL NEMATODES AND TICK-BORNE DISEASE DRIVE SYSTEMIC ENDECTOCIDE AND ACARICIDE DEMAND

10.3.2

PIG

10.3.2.1

GROWING SURGICAL VOLUME FOR ACUTE CONDITIONS IN SWINE TO DRIVE MARKET GROWTH

10.3.3

POULTRY

10.3.3.1

GROWING FOCUS ON INFECTION PREVENTION AND FLOCK HEALTH MANAGEMENT PROPELS GROWTH

10.3.4

SHEEP & GOAT

10.3.4.1

GROWTH IN CONSUMPTION OF SHEEP AND GOAT MEAT TO DRIVE MARKET

10.3.5

OTHER LIVESTOCK ANIMALS

ANIMAL PARASITICIDES MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 4 Data Tables

183

11.1

INTRODUCTION

11.2

VETERINARY HOSPITALS & CLINICS

11.2.1

VETERINARY HOSPITALS & CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD

11.3

ANIMAL FARMS

11.3.1

GROWING IMPORTANCE AND OPPORTUNITIES IN ON-FARM PARASITE MANAGEMENT

11.4

HOME CARE SETTINGS

11.4.1

RISING PET EXPENDITURE TO PROPEL MARKET GROWTH

ANIMAL PARASITICIDES MARKET, BY REGION

Comprehensive coverage of 8 Regions with country-level deep-dive of 22 Countries | 331 Data Tables.

189

12.1

INTRODUCTION

12.2

NORTH AMERICA

12.2.1

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

12.2.2

NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)

12.2.3

12.2.3.1

SURGE IN ANIMAL HEALTHCARE EXPENDITURE TO BOOST MARKET GROWTH

12.2.4

CANADA

12.2.4.1

GROWING PET OWNERSHIP AND INCREASING FOCUS ON PREVENTIVE ANIMAL HEALTHCARE TO DRIVE MARKET GROWTH

12.3

EUROPE

12.3.1

MACROECONOMIC OUTLOOK FOR EUROPE

12.3.2

EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)

12.3.3

GERMANY

12.3.3.1

STRONG FOCUS ON ANIMAL WELFARE AND ADVANCED VETERINARY CARE TO DRIVE MARKET GROWTH

12.3.4

12.3.4.1

INCREASING PET OWNERSHIP AND RISING ANIMAL HEALTHCARE SPENDING TO PROPEL MARKET GROWTH

12.3.5

FRANCE

12.3.5.1

HIGH STANDARDS OF VETERINARY CARE AND TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH

12.3.6

ITALY

12.3.6.1

GROWING PET OWNERSHIP AWARENESS AND INCREASING LIVESTOCK POPULATION TO DRIVE MARKET GROWTH

12.3.7

SPAIN

12.3.7.1

INCREASING AWARENESS REGARDING ANIMAL HEALTH TO DRIVE MARKET GROWTH

12.3.8

NETHERLANDS

12.3.8.1

GROWING PET OWNERSHIP AND STRONG LIVESTOCK SECTOR TO SUPPORT MARKET GROWTH

12.3.9

SWEDEN

12.3.9.1

GROWING COMPANION ANIMAL CARE AND ADVANCED VETERINARY INFRASTRUCTURE SUPPORTING MARKET GROWTH

12.3.10

POLAND

12.3.10.1

RAPID EXPANSION OF POULTRY PRODUCTION AND EXPORT-ORIENTED FARMING INCREASES DEMAND

12.3.11

REST OF EUROPE

12.4

ASIA PACIFIC

12.4.1

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

12.4.2

ASIA PACIFIC: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)

12.4.3

CHINA

12.4.3.1

CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

12.4.4

JAPAN

12.4.4.1

RISING PET CARE EXPENDITURE AND INCREASING ADOPTION OF COMPANION ANIMALS TO DRIVE MARKET GROWTH

12.4.5

INDIA

12.4.5.1

INCREASING LIVESTOCK POPULATION TO PROPEL MARKET GROWTH

12.4.6

AUSTRALIA

12.4.6.1

GROWING COMPANION ANIMAL OWNERSHIP AND RISE IN ANIMAL HEALTH AWARENESS TO SUPPORT MARKET GROWTH

12.4.7

SOUTH KOREA

12.4.7.1

GROWING PET OWNERSHIP TO FAVOR GROWTH

12.4.8

THAILAND

12.4.8.1

GROWING FOCUS ON LIVESTOCK HEALTH AND DISEASE PREVENTION TO DRIVE MARKET GROWTH

12.4.9

NEW ZEALAND

12.4.9.1

GROWING PET OWNERSHIP AND FOCUS ON PREVENTIVE ANIMAL HEALTHCARE TO SUPPORT MARKET GROWTH

12.4.10

REST OF ASIA PACIFIC

12.5

LATIN AMERICA

12.5.1

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

12.5.2

LATIN AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)

12.5.3

BRAZIL

12.5.3.1

BRAZIL TO DOMINATE LATIN AMERICAN MARKET

12.5.4

MEXICO

12.5.4.1

ROBUST LIVESTOCK BASE AND GROWING COMPANION ANIMAL CARE DRIVE MARKET

12.5.5

ARGENTINA

12.5.5.1

EXPANDING LIVESTOCK PRODUCTION AND INCREASING FOCUS ON DISEASE PREVENTION TO DRIVE MARKET GROWTH

12.5.6

REST OF LATIN AMERICA

12.6

MIDDLE EAST & AFRICA

12.6.1

MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

12.6.2

MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)

12.7

GCC COUNTRIES

12.7.1

KINGDOM OF SAUDI ARABIA (KSA)

12.7.1.1

MARKET GROWTH DRIVEN BY VISION 2030 INVESTMENTS

12.7.2

UNITED ARAB EMIRATES (UAE)

12.7.2.1

INCREASING FOCUS ON LIVESTOCK HEALTH AND COMPANION ANIMAL CARE TO SUPPORT MARKET GROWTH

12.7.3

OTHER GCC COUNTRIES

12.7.4

REST OF MIDDLE EAST & AFRICA

COMPETITIVE LANDSCAPE

Discover top strategies and emerging leaders shaping the animal parasiticides market landscape.

326

13.1

INTRODUCTION

13.1.1

KEY STRATEGIES ADOPTED BY PLAYERS IN ANIMAL PARASITICIDES MARKET

13.2

REVENUE ANALYSIS, 2023–2025

13.3

GLOBAL MARKET SHARE ANALYSIS, 2025

13.3.1

US ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025

13.3.2

EUROPE ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025

13.4

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024

13.4.1

STARS

13.4.2

EMERGING LEADERS

13.4.3

PERVASIVE PLAYERS

13.4.4

PARTICIPANTS

13.4.5

COMPANY FOOTPRINT: KEY PLAYERS, 2025

13.4.5.1

COMPANY FOOTPRINT

13.4.5.2

REGION FOOTPRINT

13.4.5.3

PRODUCT TYPE FOOTPRINT

13.4.5.4

ANIMAL TYPE FOOTPRINT

13.5

COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025

13.5.1

PROGRESSIVE COMPANIES

13.5.2

RESPONSIVE COMPANIES

13.5.3

DYNAMIC COMPANIES

13.5.4

STARTING BLOCKS

13.5.5

COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025

13.5.5.1

LIST OF STARTUPS/SMES

13.5.5.2

COMPETITIVE BENCHMARKING OF STARTUPS/SMES

13.6

COMPANY VALUATION AND FINANCIAL METRICS

13.7

PRODUCT/BRAND COMPARISON

13.8

COMPETITIVE SITUATIONS & TRENDS

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

347

14.1

KEY PLAYERS

14.1.1

ZOETIS INC.

14.1.1.1

BUSINESS OVERVIEW

14.1.1.2

PRODUCTS OFFERED

14.1.1.3

RECENT DEVELOPMENTS

14.1.1.3.1

PRODUCT LAUNCHES & APPROVALS

14.1.1.3.2

EXPANSIONS

14.1.1.3.3

OTHER DEVELOPMENTS

14.1.1.4

MNM VIEW

14.1.1.4.1

RIGHT TO WIN

14.1.1.4.2

STRATEGIC CHOICES

14.1.1.4.3

WEAKNESSES AND COMPETITIVE THREATS

14.1.2

MERCK & CO., INC

14.1.3

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

14.1.4

ELANCO

14.1.5

VIRBAC

14.1.6

CEVA

14.1.7

VETOQUINOL

14.1.8

NORBROOK

14.1.9

BIMEDA CORPORATE

14.1.10

KYORITSU SEIYAKU CORPORATION

14.1.11

KRKA, D. D., NOVO MESTO

14.1.12

ECO - ANIMAL HEALTH LTD.

14.1.13

ALIVIRA ANIMAL HEALTH LIMITED

14.1.14

OUROFINO SAÚDE ANIMAL

14.1.15

HEBEI VEYONG PHARMACEUTICAL CO., LTD.

14.2

OTHER PLAYERS

14.2.1

CHANELLE PHARMA

14.2.2

PETIQ LLC

14.2.3

HUVEPHARMA

14.2.4

CALIER

14.2.5

ABBEY LABS

14.2.6

BIOGÉNESIS BAGÓ

14.2.7

VETANCO SA

14.2.8

HESTER BIOSCIENCES LIMITED

14.2.9

BRILLIANT BIO PHARMA

14.2.10

ASHISH LIFE SCIENCE

RESEARCH METHODOLOGY

412

15.1

RESEARCH APPROACH

15.2

RESEARCH METHODOLOGY DESIGN

15.2.1

SECONDARY RESEARCH

15.2.1.1

KEY DATA FROM SECONDARY SOURCES

15.2.2

PRIMARY DATA

15.2.2.1

KEY DATA FROM PRIMARY SOURCES

15.2.2.2

KEY INDUSTRY INSIGHTS

15.3

MARKET SIZE ESTIMATION

15.3.1

APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)

15.3.2

APPROACH 2: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS

15.3.3

APPROACH 3: DEMAND-SIDE ANALYSIS

15.3.4

APPROACH 4: TOP-DOWN APPROACH

15.3.5

APPROACH 5: BOTTOM-UP APPROACH

15.4

MARKET BREAKDOWN & DATA TRIANGULATION

15.5

MARKET SHARE ESTIMATION

15.6

RESEARCH ASSUMPTIONS

15.7

RISK ASSESSMENT

15.8

RESEARCH LIMITATIONS

15.8.1

METHODOLOGY-RELATED LIMITATIONS

15.8.2

SCOPE-RELATED LIMITATIONS

APPENDIX

428

16.1

DISCUSSION GUIDE

16.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

16.3

CUSTOMIZATION OPTIONS

16.3.1

PRODUCT ANALYSIS

16.3.2

Methodology

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

Secondary Research

This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the animal parasiticides market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

Primary Research

In the primary research process, a range of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side included project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the animal parasiticides market. Primary sources from the demand side included R&D and product development teams at animal health companies, veterinary clinicians, procurement managers at veterinary hospitals and clinics, and purchasing heads across livestock farms and animal health distribution networks.

Animal Parasiticides Market
Size, and Share

Note: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million. C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the animal parasiticides market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Animal Parasiticides Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

Animal parasiticides or antiparasitics are medications used to prevent, mitigate, and treat internal and external parasitic infestations in companion and livestock animals. Parasiticides are usually categorized as endoparasiticides, ectoparasiticides, and endectocides. They are available in various formulations, such as oral liquids, tablets, injectables, pour-ons, spot-ons, drenches, ear tags, collars, and sprays. A parasiticide is selected depending on the type of parasite, type of animal, and the number of animals to be treated.

Key Stakeholders

Animal Parasiticide Manufacturers
Animal Parasiticide Distributors
Animal Health R&D Companies
Veterinary Clinics and Hospitals
Veterinary Pharmaceutical Associations
Veterinary Research Institutes and Universities
Venture Capitalists and Investors
Market Research and Consulting Firms
Government Associations

Report Objectives

To define, describe, segment, and forecast the animal parasiticides market by type, animal type, end user, and region
To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the market in five main regions (along with their respective key countries): North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players in the market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

Available customizations:

With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

Further breakdown of the Rest of Europe animal parasiticides market into Austria, Finland, Switzerland, and other countries
Further breakdown of the Rest of Latin America animal parasiticides market into Colombia, Chile, and other countries

Competitive Landscape Assessment

Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the animal parasiticides market
Competitive leadership mapping for established players in the US

REPORT COVERAGE

＋

REPORT OVERVIEW
KEY TAKEAWAYS
TRENDS/DISRUPTIONS IMPACT
MARKET DYNAMICS
MARKET ECOSYSTEM
MARKET SEGMENTS
MARKET REGION
COMPANY EVALUATION MATRIX
KEY MARKET PLAYERS
REPORT SCOPE
WHAT'S IN IT FOR YOU
DELIVERED CUSTOMIZATION
RECENT DEVELOPMENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report

Fact checked

Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

Triangulate with your Own Data
Get Data as per your Format and Definition
Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
Any level of Personalization

Request A Free Customisation

Let Us Help You

What are the Known and Unknown Adjacencies Impacting the Animal Parasiticides Market
What will your New Revenue Sources be?
Who will be your Top Customer; what will make them switch?
Defend your Market Share or Win Competitors
Get a Scorecard for Target Partners

Customized Workshop Request

TESTIMONIALS

JAYANT RAJPUROHIT

Director of Market Insights, Data and Analytics

SFI Health,

Leading Pharmaceutical Company

www.sfihealth.com/

We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

BEATRIZ DE LA CALLE

Head of Commercial Analytics

Qualicaps,

Leading Pharmaceutical Company

www.qualicaps.com/

We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

Bob Williams,

Senior Director Business Development & Innovation

Bracco Diagnostics Inc.,

Italian Multinational in life sciences sector and a World Leader in imaging diagnostics

imaging.bracco.com/us-en

We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.

Cody Coonradt,

Market Development and Strategy Manager

3M Health Information Systems,

Leader in Health care Coding, Payment & Analytics Solutions.

www.3m.com/3M/en_US/health-information-systems-us

The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.

Their customer first approach and high value engagement model, have given us great analysis and excellent value for money

Growth opportunities and latent adjacency in Animal Parasiticides Market

Julian

Apr, 2026

We are focused on cattle. What are the key demand drivers in livestock parasiticides?.

Wyatt

Apr, 2026

What are the latest innovations in parasiticide formulations and delivery methods?.

Isaac

Apr, 2026

How is data analytics transforming veterinary clinical trial design and outcomes?.

Nolan

Apr, 2026

How significant is aquaculture in parasiticides, and what growth potential does it have?.

Ryan

Apr, 2026

We are exploring equine healthcare. Is this segment commercially attractive compared to other livestock categories?.

Connor

Apr, 2026

How important is animal behavior analysis in treatment planning and product development in this market?.

Xavier

Apr, 2026

How fragmented is the parasiticides market, and what is the role of branded vs generic products?.

Ian

Apr, 2026

How can AI-based solutions improve disease prediction and care efficiency in veterinary and animal health operations?.

Sergio

Apr, 2026

How are animal parasiticides like spot-on and pour-on treatments evolving with modern veterinary healthcare practices?.

Ethan

Apr, 2026

In the animal parasiticide market, how are manufacturers addressing resistance issues, especially with repeated use in livestock?.

Brianna

Apr, 2026

From a buyer�s perspective, rising costs of parasiticides are a concern. How can producers balance affordability with effectiveness?.

Colton

Apr, 2026

How scalable is the parasiticide market in emerging economies where veterinary infrastructure is still developing?.

Delaney

Apr, 2026

With increasing digitalization in agriculture, how is technology being integrated into parasiticide usage and monitoring?.

Griffin

Apr, 2026

What future opportunities do you see shaping the animal parasiticide market over the next decade?.

Animal Parasiticides Market by Type (Ectoparasiticide, Endoparasiticide, Endectocide, Spray, Feed Additives), Animal Type (Dog, Cat, Horse, Cattle, Pig, Poultry), End user (Hospital, Animal farm, Home Care Setting) & Region - Global Forecast to 2031

ANIMAL PARASITICIDES MARKET SIZE, SHARE & GROWTH SNAPSHOT

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

Driver: Rising pet ownership and increased focus on preventive animal healthcare

Restraint: Strict regulations on parasiticide residues in food-producing animals

Opportunity: Development of long-acting, combination, and novel-delivery parasiticides

Challenge: Increasing parasite resistance to existing active ingredients

ANIMAL PARASITICIDES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

Animal Parasiticides Market, By Type

Animal Parasiticides Market, By Animal Type

Animal Parasiticides Market, By End User

REGION

Asia Pacific to be fastest-growing region in global animal parasiticides market during forecast period

ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: ANIMAL PARASITICIDES MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

Data Triangulation

Market Definition

Key Stakeholders

Report Objectives

Available customizations:

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Adjacent Markets

Personalize This Research

Let Us Help You

TESTIMONIALS

JAYANT RAJPUROHIT

SFI Health,

BEATRIZ DE LA CALLE

Qualicaps,

Bob Williams,

Bracco Diagnostics Inc.,

Cody Coonradt,

3M Health Information Systems,

Growth opportunities and latent adjacency in Animal Parasiticides Market

Julian

Wyatt

Isaac

Nolan

Ryan

Connor

Xavier

Ian

Sergio

Ethan

Brianna

Colton

Delaney

Griffin